Glucocorticoids act in the dorsal hindbrain to increase arterial pressure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Scheuer, Deborah A ^a   Bechtold, Andrea G ^a   Shank, Sylvan S ^a   Akana, Susan F ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Corticosterone; Hypertension; Nucleus of the solitary tract

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG ANTAGONISM; DRUG IMPLANT; FOREBRAIN; HEART RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RHOMBENCEPHALON; SOLITARY TRACT NUCLEUS;

EID: 0346368247     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00824.2003     Document Type: Article

References (67)

1. Ahima RS and Harlan RE. Charting of the type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39: 579-604, 1990.
2. Akana SF, Chu A, Soriano L, and Dallman MF. Corticosterone exerts site-specific and state-dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat deposits. J Neuroendocrinol 13: 625-637, 2001.
3. Akana SF, Scribner KA, Bradbury MJ, Strack AM, Walker CD, and Dallman MF. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone. Endocrinology 131: 585-594, 1992.
4. Andresen MC and Kunze DL. Nucleus tractus solitarius-gateway to neural circulatory control. Annu Rev Physiol 56: 93-116, 1994.
5. Bechtold AG, Shank SS, and Scheuer DA. Activation of glucocorticoid receptors in the region of the nucleus of the solitary tract (NTS) and area postrema modulates baroreflex function (Abstract). FASEB J 17: A889, 2003.
6. Bjorntorp P and Rosmond R. Obesity and cortisol. Nutrition 16: 924-936, 2000.
7. Brem AS. Insights into glucocorticoid-associated hypertension. Am J Kidney Dis 37: 1-10, 2001.
8. Clapham JC and Turner NC. Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat. J Pharmacol Exp Ther 282: 1503-1508, 1997.
9. Colombari E and Talman WT. Denervation supersensitivity to glutamate in nucleus tractus solitarii after removal of the nodose ganglion. Brain Res 677: 110-116, 1995.
10. Connell JMC, Kenyon CJ, Ingram M, Holloway C, Jamieson A, Panarelli M, Inglis G, and Fraser R. Corticosteroids in essential hypertension: multiple candidate loci and phenotypic variation. Clin Exp Pharmacol Physiol 23: 369-374, 1996.
11. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, and Strack AM. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 4: 517-526, 1992.
12. Felder RB and Mifflin SW. Baroreceptor and chemoreceptor afferent processing in the solitary tract nucleus. In: Nucleus of the Solitary Tract (1st ed.), edited by Barraco IRA. Boca Raton, FL: CRC, 1994, p. 169-186.
13. Flecknell P. Medetomidine and atipamezole: potential uses in laboratory animals. Lab Animal 26: 21-24, 1997.
14. Funder JW. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 259: 1132-1133, 1993.
15. Funder JW, Pearce PT, Smith R, and Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
16. Fuxe K, Harfstrand A, Agnati LF, Yu ZY, Cintra A, Wikstrom AC, Okret S, Cantoni E, and Gustafsson JA. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brainstem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neurosci Lett 60: 1-6, 1985.
17. Gaillard RC, Riondel A, Muller AF, Herrmann W, and Baulieu EE. RU 486: a steroid with anti glucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81: 3879-3882, 1984.
18. Gardiner SM and Bennett T. Post-adrenalectomy hypotension in rats; absence of baroreflex resetting or effects of naloxone. Clin Sci (Lond) 64: 371-376, 1983.
19. Goldstein DS. Stress, Catecholamines, and Cardiovascular Diseases. New York: Oxford Univ. Press, 1995.
20. Goldstein DS and Kopin IJ. The autonomic nervous system and catecholamines in normal blood pressure control and in hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management (1st ed.), edited by Laragh JH and Brenner BM. New York: Raven, 1990, p. 711-747.
21. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, and Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258: E649-E653, 1990.
22. Grunfeld JP. Glucocorticoids in blood pressure regulation. Horm Res 34: 111-113, 1990.
23. Hardman JG, Limbird LE, and Goodman Gilman A. The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001.
24. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC, Okret S, Yu ZY, Goldstein M, Steinbusch H, Verhofstad A, and Gustafsson JA. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci USA 83: 9779-9783, 1986.
25. Hashimoto K, Makino S, Hirasawa R, Takao T, Sugawara M, Murakami K, Ono K, and Ota Z. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension. Endocrinology 125: 1161-1167, 1989.
26. Iglasias T, Jimenez I, Montero S, and Fuentes J. Stress-induced hypertension: effects of adrenalectomy and corticosterone replacement. Life Sci 49: 979-986, 1991.
27. Jessop DS, Dallman MF, Fleming D, and Lightman SL. Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 86: 4109-4114, 2001.
28. Kenyon CJ, Panarelli M, Holloway CD, Dunlop D, Morton JJ, Connel JMC, and Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J Steroid Biochem Mol Biol 45: 7-11, 1993.
29. Laugero KD, Gomez F, Manalo S, and Dallman MF. Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 143: 4552-4562, 2002.
30. Lin RCY, Wang XL, and Morris BJ. Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41: 4044-407, 2003.
31. Lin RCY, Wang YSW, and Morris BJ. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension 34: 1186-1192, 1999.
32. McEwen BS, De Kloet ER, and Rostene W. Adrenal steroid receptors and actions in the central nervous system. Physiol Rev 66: 1121-1188, 1986.
33. Moguilewsky M and Philibert D. Biochemical profile of RU 486. In: The Antiprogestin Steroid RU 486 and Human Fertility Control, edited by Baulieu E and Segal SJ. New York: Plenum, 1985, p. 87-97.
34. Olbinskaya LI, Golubev SA, and Bolshakova TD. Influence of benzazepril and captopril on blood pressure in essential hypertensives. J Hum Hypertens 7: 603-606, 1993.
35. Pesonen U, Koulu M, Heikinheimo O, and Huupponen R. The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrencortical system in obese Zucker rats. J Endocrinol 132: 425-431, 1992.
36. Philibert D, Moguilewsky M, Mary L, Lecaue D, Tournemine C, Secchi J, and Deraedt R. Pharmacological profile of RU 486 in animals. In: The Antiprogestin Steroid RU 486 and Human Fertility Control, edited by Baulieu E and Segal SJ. New York: Plenum, 1985, p. 49-68.
37. Rajpert EJ, Lemaigre FP, Eliard PH, Place M, Lafontaine DA, Economidis IV, Belayew A, Martial JA, and Rousseau GG. Glucocorticoid receptors bound to the antagonist RU486 are not downreulated despite their capacity to interact in vitro with defined gene regions. J Steroid Biochem 26: 513-520, 1987.
38. Reul JMHM and De Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511, 1985.
39. Roland BL, Li KXZ, and Funder JW. Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in the rat brain. Endocrinology 136: 4697-4699, 1995.
40. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, and Bjorntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 8: 211-218, 2000.
41. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, and Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85: 1440-1448, 2000.
42. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens Res 19: 1-8, 1996.
43. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, and Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab 62: 275-279, 1986.
44. Scheuer DA and Bechtold AG. Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure. Am J Physiol Regul Integr Comp Physiol 280: R1719-R1726, 2001.
45. Scheuer DA and Bechtold AG. Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats. Am J Physiol Regul Integr Comp Physiol 282: R475-R483, 2002.
46. Scheuer DA and Mifflin SW. Chronic corticosterone treatment increases myocardial infarct size in rats with ischemia-reperfusion injury. Am J Physiol Regul Integr Comp Physiol 272: R2017-R2024, 1997.
47. Scheuer DA and Mifflin SW. Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 280: R1440-R1449, 2001.
48. Seckl JR. Physiologic programming of the fetus. Clin Perinatol 25: 939-962, 1998.
49. Segar JL, Bedell KA, and Smith OJ. Glucocorticoid modulation of cardiovascular and autonomic function in preterm lambs: role of ANG II. Am J Physiol Regul Integr Comp Physiol 280: R646-R654, 2001.
50. Segar JL, Lumbers ER, Nuyt AM, Smith OJ, and Robillard JE. Effect of antenatal glucocorticoids on sympathetic nerve activity at birth in preterm sheep. Am J Physiol Regul Integr Comp Physiol 274: R160-R167, 1998.
51. Segar JL, Van Natta T, and Smith OJ. Efects of fetal ovine adrenalectomy on sympathetic and baroreflex responses at birth. Am J Physiol Regul Integr Comp Physiol 283: R460-R467, 2002.
52. Shank SS and Scheuer DA. Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius. Am J Physiol Heart Circ Physiol 284: H1751-H1761, 2003.
53. Sholter DE and Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 16: 505-511, 2000.
54. Soro A, Ingram MC, Tonolo G, Glorioso N, and Fraser R. Mildly raised corticosterone excretion rates in patients with essential hypertension. J Hum Hypertens 9: 391-393, 1995.
55. Sun MK. Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 47: 157-233, 1995.
56. Suzuki H, Zweifach BW, and Schmid-Schonbein GW. Dependence of elevated mesenteric arteriolar tone on glucocorticoids in spontaneously hypertensive rats. Int J Microcirc Clin Exp 15: 309-315, 1995.
57. Takahashi H, Takeda K, Ashizawa H, Inoue A, Yoneda S, Yoshimura M, and Ijichi H. Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats. Am J Physiol Heart Circ Physiol 245: H1013-H1018, 1983.
58. Thrasher TN. Unloading arterial baroreceptors causes neurogenic hypertension. Am J Physiol Regul Integr Comp Physiol 282: R1044-R1053, 2002.
59. Tonolo G, Soro A, Madeddu P, Troffa C, Melis MG, Patteri G, Pinna Parpaglia P, Sabino G, Maioli M, and Glorioso N. Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats. Am J Physiol Endocrinol Metab 264: E843-E847, 1993.
60. Udelsman R, Ramp J, Gallucci WT, Gordon A, Lipford E, Norton JA, Loriaux DL, and Chrousos GP. Adaptation during surgical stress: a reevaluation of the role of glucocorticoids. J Clin Invest 77: 1377-1381, 1986.
61. Ukkola O, Rosmond R, Tremblay A, and Bouchard C. Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis 157: 221-224, 2001.
62. Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41: 55-64, 1999.
63. Van den Berg DTWM, De Kloet ER, van Dijken HH, and de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 126: 118-124, 1990.
64. Villeneuve A, Gignae S, and Provencher PH. Glucocorticoids decrease endothelin-A- and endothelin-B-receptor expression in the kidney. J Cardiovasc Pharmacol 36, Suppl 1: S238-S240, 2000.
65. Walker BR, Best R, Shackleton CHL, Padfield PL, and Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 27: 190-196, 1996.
66. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Conner JM, Lever AF, and Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10: 473-482, 1992.
67. Whitworth JA, Mangos GJ, and Kelley JJ. Cushing, cortisol and cardiovascular disease. Hypertension 36: 912-916, 2000.